A-Squared Ventures

Venture Capital Active Herzliya, Israel Est. 2020
Visit website ↗ LinkedIn
Last updated 2026-06-18
Portfolio
5
in our dataset
Rounds participated
9
Rounds led
0
Rounds' value
$110.8M
total disclosed, rounds participated
Stages
A Round, Seed, Pre-Seed

About

A² Ventures funds entrepreneurs harnessing software to solve unmet needs in US healthcare.

The firm is a dedicated early-stage digital health fund, operating in NY and Tel Aviv, supported by Arkin Capital, strategic institutional investors, and individuals as our LPs. The firm is focused on B2B and B2B2C software-based companies (healthcare IT, tech-centered care delivery, and pharmatech) operating in the US market and looking to lead or co-lead investments in pre-seed to early series A rounds.

A² Ventures leverages its deep connections with Arkin Capital’s infrastructure, $2 B AUM and extensive cross-sector exposure, with a particular focus on healthcare and life sciences.

Portfolio · 5

Rhino Federated Computing
Federated Computing Platform for Secure Decentralized Data Collaboration
3 rounds $26.7M committed Latest: 2025-05
Eleos Health
Automated Behavioral Care Workflow Solution
3 rounds $66.0M committed Latest: 2023-11
Nest Health
Genomics Software Solutions for Health Systems
1 round $8.5M committed Latest: 2023-01
Laguna Health
Conversational Care Intelligence
1 round $6.6M committed Latest: 2021-05
Edocate
HCP Engagement by Patient Simulation Cases
1 round $3.0M committed Latest: 2021-04

Investment activity

Portfolio by sector

Health Tech & Life Sciences5
Undisclosed1
Education & Knowledge Technologies1

Funds · 2

  • II — $40M Nov 2025
  • I — $10M Jan 2021

Q&A

What is A-Squared Ventures' primary investment focus?
A-Squared Ventures is a dedicated early-stage digital health fund, focusing on B2B and B2B2C software-based companies in healthcare IT, tech-centered care delivery, and pharmatech, operating in the US market.
What investment stages does A-Squared Ventures typically target?
A-Squared Ventures typically targets Pre-Seed to early Series A rounds, and also participates in Seed and A Round stages.
When was A-Squared Ventures founded?
A-Squared Ventures was founded in 2020.
Which notable companies are in A-Squared Ventures' portfolio?
A-Squared Ventures' portfolio includes Eleos Health.
What is the most recent fund raised by A-Squared Ventures?
A-Squared Ventures raised Fund II, amounting to $40M, in November 2025.
Who are some key team members at A-Squared Ventures?
Key team members at A-Squared Ventures include Nadav Shimoni, Managing Director, and Sam Cronin, Partner.
What is A-Squared Ventures' geographic focus for investments?
A-Squared Ventures focuses on companies operating in the US market, with operations in NY and Tel Aviv.
What is the sector concentration of A-Squared Ventures' investments?
The majority of A-Squared Ventures' investments, 13 rounds, are in Health Tech & Life Sciences.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)